NSPR InspireMD Inc: Debt to Equity
The market trend for InspireMD, Inc. (NSPR) shares on the GURU.Markets platform demonstrates a value of 0.10, while the business ensures the precise delivery of vascular stents for urgent interventions, maintaining high margins through various distributors. Expansion in the US and the loyalty of European surgeons to CGuard networks awaiting FDA clearance are driving base growth. Revenues are based on the sale of advanced brain protection systems for surgical procedures.
%20Aggregate%20Debt%20to%20Equity&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_NSPR_-_InspireMD-Inc._-_Aggregate-Debt-to-Equity "InspireMD Corp - NSPR Total Debt to Capital (period 07/04/2022 - 10/29/2026) | 👁️GURU.Markets👁️")
NSPR (InspireMD Inc.): analytical breakdowns and indicator data
The total debt-to-equity ratio measures the proportion of borrowed funds within the financing structure, determining the business's dependence on creditors and the stability of its balance sheet. Analyzing the debt-to-equity chart allows for an assessment of the financial leverage of InspireMD, Inc. (NSPR) while scaling the CGuard system, where controlling indebtedness is critical for integrating innovative vascular protection meshes into the medical standard.